Levesam 500 Eazy Glide Tablet contains Levetiracetam 500 mg, an antiepileptic medication indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby reducing neuronal excitability and seizure propagation. This tablet formulation is designed for ease of swallowing and rapid dissolution, enhancing patient compliance. Levesam 500 is typically administered orally, with dosage individualized based on patient age, renal function, and clinical response. Common adverse effects may include somnolence, dizziness, headache, and fatigue, with serious but rare risks such as behavioral changes and hypersensitivity reactions. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Levesam 500 should be used under medical supervision, with regular monitoring for efficacy and tolerability. It is contraindicated in patients with known hypersensitivity to Levetiracetam or any tablet excipients. This medication does not replace other antiepileptic drugs unless directed by a healthcare professional. Patients are advised to adhere strictly to prescribed dosing schedules and report any unusual symptoms promptly. Levesam 500 Eazy Glide Tablet offers an effective option for seizure management with a favorable safety profile.